A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer. (Q34205971)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer. |
scientific article |
Statements
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer (English)
Jianqing Lin
Marianna Zahurak
Tomasz M Beer
Charles J Ryan
Paul Mathew
Jennifer A Callahan
Gilad Gordon
Steven D Reich
Michael A Carducci
4 August 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference